Washington, DC 5/22/14—Roka Biosciences has filed to raise $75.0 million through a US IPO. Roka plans to list its shares on the NASDAQ stock exchange. Pricing details were not announced. Roka offers the Atlas instrument and Atlas Detection Assays for molecular-based automated foodborne-pathogen testing. Roka supplies tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin–producing […]
New York, NY 5/22/14—The Wall Street Journal reported that VWR is in talks about a possible IPO or sale, according to sources. VWR and owner Madison Dearborn Partners have talked with banks in recent weeks about an IPO to raise $750 million. Such an offering would value the equity in VWR at $4 billion. As […]
The calendar year first quarter provided few clear trends as large publicly held US analytical and life science instrument firms experienced mixed results, with strengths and weaknesses in market and geographic segments varying by company. The six laboratory instrument and product businesses whose quarterly revenues are detailed on pages 9–11 reported positive sales results for […]
Thermo Fisher Scientific and Life Technologies made their financial-reporting debut as one company (see IBO 4/15/13) with the release of Thermo’s first quarter earnings in April. The industry-changing acquisition united two of the top five analytical and life science instrument firms (see IBO 4/15/14), creating a company whose financial size and breadth of products dwarf […]
Company Announcements In January, Bruker named Andy Boorn as president of its CAM division. Mr. Boorn previously served as president of AB SCIEX. Bruker also announced plans to narrow CAM’s strategic focus. In February, the company merged the commercial management organizations of its CAM and LSC divisions. In February, Avacta named Michael Albin, PhD, to […]
First quarter revenue growth for IBO’s Laboratory Instrument Sales Index jumped 7.3%, 6.8% excluding currency, to $6,308 million. Adjusted operating profit advanced 13.5% to $1,376 million, and operating margin expanded 20 basis points to 18.3% of sales. Financial estimates are included for Oxford Instruments, Spectris and Tecan, which have yet to report first quarter financial […]
Santa Clara, CA 5/1/14; Washington, DC 5/1/14—ProteinSimple, a provider of systems and consumables for protein analysis, has announced the filing of a registration statement with the SEC for an IPO. The company’s common stock will be listed on the NASDAQ Global Stock Market under the symbol “PRTN.” The number of shares to be offered and […]
Mixed financial results influenced compensation in fiscal 2013 (FY13) as just over half of the top executives in IBO’s Stock Indexes recorded higher pay, according to IBO’s latest review of US instrument and lab product companies’ executive compensation. For the 34 CEOs and/or presidents from the 32 companies in the Indexes who have served in […]
According to the latest IBO Business Climate Survey, optimism among executives at analytical instrument and lab product companies and associated suppliers is on the upswing. Seventy-three percent of executives surveyed expect sales for the industry as a whole to increase moderately in the second and third quarters (see graph, page 4). This is a notable […]
The recent and upcoming expiration of patents on several blockbuster drugs and resulting loss of revenue will require pharmaceutical companies to search for new means to grow revenues. Megamergers, which were common in the past, will still occur. However, recent acquisitions by many pharmaceutical firms show a move instead to specialize in specific markets. For […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
